Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Bird Flu

<< Previous

Bullboard Posts

Next >>

Comment by CancerSlayeron Jun 17, 2024 1:38pm

171 Views

Post# 36092441

RE:RE:RE:RE:RE:RE:Bird Flu

And of course there was Operation Warp Speed in the US...a public-private patnership wherein over $18 Billion of US public funds were invested in multiple vaccine candidates produced by Big Pharma, which included AstraZeneca, Moderna, J&J & Sanofi.

gebremeskel wrote: I believe you are mistaken. Through the Strategic Innovation Fund the government awarded -

"$600 million to support COVID-19 vaccine and therapy clinical trials led by the private sector, and for Canadian bio-manufacturing opportunities"

https://ised-isde.canada.ca/site/biomanufacturing/en/backgrounder-government-canada-investments-biomanufacturing-vaccine-and-therapeutics-ecosystem

Publicly traded AbCellera, for example, received $300 million

"The federal government is contributing $225 million towards the new facility through its Strategic Innovation Fund, and the B.C. government is contributing $75 million.

“This project, and the commitment to co-invest alongside the governments of Canada and British Columbia, is a major step towards building the capabilities in Canada to translate scientific breakthroughs into new medicines that will benefit patients here and around the world,” said AbCellera founder and CEO Carl Hansen."

https://www.biv.com/news/technology/abcellera-draws-300-million-government-funding-8271796

menoalittle wrote: >> A grant would be most welcome. But don't those things take forever to work out?

Unless I'm mistaken, government grants either aren't available or aren't typically given to a publically traded company. Consequently, I'm honestly not expecting one. (Of course, that doesn't mean that I think there's something else brewing. The stock wants to trade up, but someone seems to still be sitting on it for some reason. Guess we'll all know more by the end of the week...)